Yüklüyor......
ACS Chemical Neuroscience Molecule Spotlight on Fanapt
[Image: see text] The new mixed dopamaine D(2)/serotonin 5-HT(2A) antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Chemical Society
2010
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368683/ https://ncbi.nlm.nih.gov/pubmed/22778835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn100024g |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|